Claxton,, Lindsay orcid.org/0000-0002-1795-7568, Hodgson, Robert orcid.org/0000-0001-6962-2893, Malcom, William et al. (2 more authors) (2016) Simulation Modelling in Ophthalmology:Application to Cost Effectiveness of Ranibizumab and Aflibercept for the Treatment of Wet Age-Related Macular Degeneration in the United Kingdom. PharmacoEconomics. pp. 1-12. ISSN 1179-2027
Abstract
Previously developed models in ophthalmology have generally used a Markovian structure. There are a number of limitations with this approach, most notably the ability to base patient outcomes on best-corrected visual acuity (BCVA) in both eyes, which may be overcome using a different modelling structure. Simulation modelling allows for this to be modelled more precisely, and therefore may provide more accurate and relevant estimates of the cost effectiveness of ophthalmology interventions.
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York) |
Depositing User: | Pure (York) |
Date Deposited: | 14 Dec 2016 09:37 |
Last Modified: | 08 Feb 2025 00:21 |
Published Version: | https://doi.org/10.1007/s40273-016-0459-z |
Status: | Published |
Refereed: | Yes |
Identification Number: | 10.1007/s40273-016-0459-z |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:109417 |
Download
Filename: Simulation_Modelling_in_Ophthalmology_v3.1_clean_.pdf
Description: Simulation Modelling in Ophthalmology final version